Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (246)
- Medicines safety (146)
- COVID-19 (144)
- Prescription medicines (129)
- Regulatory compliance (120)
- COVID-19 vaccines (88)
- Legislation (78)
- Therapeutic goods regulation (71)
- Listed medicines (48)
- Non-prescription medicines (43)
- Medical devices safety (42)
- Safety (40)
- Vaping hub (33)
- Complementary medicines (30)
- Manufacturing (28)
- Assessed listed medicines (24)
- Labelling and packaging (22)
- Over the counter (OTC) medicines (21)
- Compliance and enforcement hub (20)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (20)
- Import and export (19)
- Australian Register of Therapeutic Goods (ARTG) (17)
- Alert/Advisory (12)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Registered complementary medicines (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1052 result(s) found, displaying 276 to 300
-
Media releasesThe TGA is calling for anyone using a Philips Continuous Positive Airway Pressure (CPAP) machine or a Bi-level Positive Airway Pressure (Bi-Level PAP) machine to see if they are affected by the recall action.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NewsFind out about the requirements starting on 1 January 2023 for medicines that are serialised or include a data matrix code.
-
Media releasesThe TGA has issued one infringement notice to Queensland-based IMUNI Pty Ltd for allegedly advertising a complementary medicine for a therapeutic use that was not permitted.
-
Safety updatesMedicines Safety Update - Information for health professionals.
-
Media releasesThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on their websites and social media platforms.
-
Media releasesThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on a website and through social media.
-
NewsThe TGA urges consumers to steer clear of using products containing 'Melanotan'
-
Media releasesThe TGA has provisionally approved Pfizer’s bivalent COVID-19 vaccine, tozinameran and riltozinameran (COMIRNATY Original/Omicron BA.1) for use as a booster dose in adults 18 years and over.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesOn 19 October 2022, the TGA provisionally approved Moderna's COVID-19 vaccine, SPIKEVAX (elasomeran), for use as a booster dose in individuals aged 12 years and older.
-
Media releasesInspire Cosmetology Pty Ltd fined $26,640 for alleged unlawful import of cosmetic injectable products
-
Media releasesNSW medical practitioner fined for allegedly illegally importing prescription medicines
-
NewsThe Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.
-
Media releasesThe TGA has issued two infringement notices totalling $5,328 to a Queensland-based individual for the alleged unlawful use of a prohibited representation and endorsement in advertising a listed complementary medicine.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
NewsTell us your experience using of the beta Database of Adverse Event Notifications (DAEN) - medicines.
-
Media releasesThe TGA has granted a provisional determination to Moderna Australia Pty Ltd’s bivalent COVID-19 vaccine candidate: elasomeran and davesomeran (SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4/BA.5)
-
Media releasesThe TGA has provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, COMIRNATY (tozinameran), for children aged 6 months to less than 5 years
-
Media releasesBest Body Industries Pty Ltd fined for alleged unlawful advertising of sports supplements
-
NoticesThe TGA has issued a direction notice to MDNE Enterprises Pty Ltd to cease promoting the use and supply of nicotine vaping products to the Australian public.
-
Media releasesDirection and infringement notices given to MDNE Enterprises Pty Ltd for alleged unlawful advertising of nicotine vaping products
-
Media releasesFines totalling $972,360 given to three medicinal cannabis companies for alleged unlawful advertising
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.